Genotype Distribution and Prevalence of High-Risk Human Papillomavirus Infection among Women in Samsun Province of Turkey

Background: The human papillomavirus (HPV) is an important public health problem that can cause cervical cancer. HPVs were classified into high-risk (HR-HPV) and low-risk (LR-HPV) types. In this study, we aimed to determine the prevalence and genotype distribution of HR-HPV infection in Samsun province in Turkey. Methods: Cervical smear samples taken from 5406 women over a 23-month period were evaluated for the presence of HPV infection. The detection of HPV genotypes was performed using RT-PCR technology. HPV detection and genotyping were performed using RT-PCR method. HR- HPV types are divided into 3 groups as type 16, type 18 and other types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, with or without type 16 and 18). The results were evaluated statistically. Results: The mean age of HR-HPV positive patients was 39.56 years (20-68 years). The prevalance of HR-HPV types did not differ between different age groups (p˃0.05). Overall, 9.17% of women (496/5406 samples) were found to be positive at least one type of HR-HPV. HPV type 16 was detected in 28.62%, type 18 in 9.67%, and other types in 78.83%. The most common HR-HPV type was other types (p˂0.001). Type 16 was most common than type 18 (p˂0.001). The patients were evaluated by dividing them into 6 age groups. Type 16 positivity was higher in 30-39 ages while type18 and other types positivity were higher in the 40-49 age group. When the 23-month period of HPV test was evaluated according to months and seasons, the highest prevalance was seen in June 2021 and Summer 2021. Conclusion: To our knowledge, this is the first large-scale study of HR-HPV prevalence and genotype distribution among women in Samsun Province of Turkey. The other types containing one or more types made up the majority of the studied population.

[1]  Sema Alaçam,et al.  Human Papillomavirus Prevalence and Genotype Distribution in Cervical Swab Samples in Istanbul, Turkey. , 2021, Journal of infection in developing countries.

[2]  Fang Wang,et al.  Prevalence characteristics of human papillomavirus (HPV) infection among women receiving physical examinations in the Shangcheng District, Hangzhou city, China , 2021, Scientific Reports.

[3]  S. Eğrilmez,et al.  The COVID-19 Pandemic: Clinical Information for Ophthalmologists , 2020, Turkish journal of ophthalmology.

[4]  H. Banerjee,et al.  Human Papilloma Virus-Associated Cervical Cancer and Health Disparities , 2019, Cells.

[5]  M. Acar,et al.  Prevalence of Human Papilloma Virus Types in Turkish and Albanian Women , 2018, Journal of cytology.

[6]  P. Ulug,et al.  Estimation of the prevalence and distribution of HPV genotypes and identification of related risk factors among Turkish women , 2017, Contemporary oncology.

[7]  D. Cui,et al.  Analysis of epidemiological trends in human papillomavirus infection among gynaecological outpatients in Hangzhou, China, 2011–2015 , 2017, BMC Infectious Diseases.

[8]  J. Pierce,et al.  Morbidity and mortality of vulvar and vaginal cancers: Impact of 2-, 4-, and 9-valent HPV vaccines , 2016, Human vaccines & immunotherapeutics.

[9]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[10]  W. Quint,et al.  Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia , 2014, BMC Infectious Diseases.

[11]  Yong Jiang,et al.  The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China , 2014, Virology Journal.

[12]  W. Quint,et al.  An epidemiological study assessing the prevalence of human papillomavirus types in women in the Kingdom of Bahrain , 2014, BMC Cancer.

[13]  H. Chesson,et al.  The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States , 2014, Sexually transmitted diseases.

[14]  R. Sankaranarayanan Screening for cancer in low- and middle-income countries. , 2014, Annals of global health.

[15]  Sunmie Kim,et al.  Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: Data from the health check-ups of 7,014 Korean women , 2013, Obstetrics & gynecology science.

[16]  M. Ceyhan,et al.  The prevalence of different HPV types in Turkish women with a normal Pap smear , 2012, Journal of medical virology.

[17]  Virginia Sánchez Monroy,et al.  Prevalence of Human Papillomavirus in Women from Mexico City , 2012, Infectious diseases in obstetrics and gynecology.

[18]  Shulan Zhang,et al.  The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China , 2012, BMC Cancer.

[19]  G. Sotgiu,et al.  Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy , 2011, BMC public health.

[20]  L. Bruni,et al.  Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. , 2010, The Journal of infectious diseases.

[21]  E. de Villiers,et al.  Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. , 2010, Virology.

[22]  E. Unger,et al.  Human Papillomavirus and Cervical Cancer , 2004, Emerging infectious diseases.

[23]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[24]  S. Eroğlu,et al.  Frequency and genotype distribution of high-risk human papilloma virus types in Karabuk province, Turkey: A hospital based cross-sectional study , 2020, Annals of Medical Research.

[25]  S. Aydoğan,et al.  The presence and distribution of high risk HPV types in simultaneous cervical cytology samples , 2018 .

[26]  M. Gokcu,et al.  Prevalence of high–risk human papillomavirus in women from turkey , 2015 .

[27]  S. Akçalı,et al.  Human papilloma virus frequency and genotype distribution in a Turkish population. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[28]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.